Advertisement

Benzodiazepine Use

  • Curtis L. BaysingerEmail author
Chapter

Abstract

Benzodiazepine abuse alone is uncommon. The duration of action is significantly variable between specific drugs, so the course of withdrawal can be very variable. The associations between benzodiazepine abuse and an increased rate of congenital defects cited in older case-controlled studies have not been confirmed in newer reports, and long-term child behavioral deficits have not been reported. Preterm delivery is more likely as with maternal abuse of other drugs. Acute withdrawal can be life threatening, and tapering of drug should incorporate symptom-driven protocols. Anesthetic requirements may be increased in the chronically abusing parturient.

Keywords

Addiction Obstetric anesthesia Benzodiazepine Congenital anomalies 

References

  1. 1.
    Goplan P, Galance JB, Azzam PN. Managing benzodiazepine withdrawal during pregnancy. Case based guidelines. Arch Womens Ment Health. 2014;17:167–70.CrossRefGoogle Scholar
  2. 2.
    Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014.Google Scholar
  3. 3.
    American College of Obstetricians and Gynecologists. Committee opinion number 538: nonmedical use of prescription drugs. Obstet Gynecol. 2012;120:977–82.CrossRefGoogle Scholar
  4. 4.
    Reynolds EW, Bada HS. Pharmacology of drugs of abuse. Obstet Gynecol Clin N Am. 2003;30:501–22.CrossRefGoogle Scholar
  5. 5.
    McLafferty LP, Becker M, Dresner N, et al. Guidelines for the management of pregnant women with substance abuse disorders. Psychosomatics. 2016;57:115–30.CrossRefGoogle Scholar
  6. 6.
    Bergman U, Rosa FW, Baum C, et al. Effects of exposure to benzodiazepines during fetal life. Lancet. 1992;340:694–6.CrossRefGoogle Scholar
  7. 7.
    Eros AE, Zeizel M, Rockenbauer HT, et al. A population-based case-controlled teratologic study of nitrazepam, medazepam, tofisopam, alprazolum, and clonazepam treatment during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2002;101:147–54.CrossRefGoogle Scholar
  8. 8.
    Helmbrecht GD, Thiagarajah S. Management of addiction disorders in pregnancy. J Addict Med. 2008;2:1–16.CrossRefGoogle Scholar
  9. 9.
    Long LP, Johnson B. Addiction: part I. Benzodiazepines—side effects, abuse risk, and alternatives. Am Fam Physician. 2000;61:2121–8.Google Scholar
  10. 10.
    D’Apoito K. Breastfeeding and substance abuse. Clin Obstet Gynecol. 2013;56:202–11.CrossRefGoogle Scholar
  11. 11.
    Ludlow J, Christmas T, Paech MJ. Drug abuse and dependency during pregnancy: anaesthetic issues. Anaesth Intensive Care. 2007;35:881–93.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyVanderbilt University Medical Center, Vanderbilt University HospitalNashvilleUSA

Personalised recommendations